LISA OSTENDORF: Open Payments
NPI 1326458019 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,097 in 52 payments from 12 companies in 2025. Trend: 2023 $4,742 · 2024 $8,553 · 2025 $4,097
Speaker / faculty: $1,813Food & beverage: $1,573Travel & lodging: $712
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $2,051 |
| Boston Scientific Corporation | 19 | $1,692 |
| VERTEX PHARMACEUTICALS INCORPORATED | 8 | $138 |
| MML US, Inc. | 4 | $51 |
| SPR Therapeutics, Inc | 1 | $27 |
| Fidia Pharma USA Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $24 |
| Forte Bio-Pharma LLC | 1 | $20 |
| SI-BONE, INC. | 1 | $19 |
| Indivior Inc. | 1 | $17 |
Products named: Intracept, UBRELVY, QULIPTA, ReActiv8, General - Pain Management, SPRINT PNS System, HYMHYN, QUTENZA.
Industry payments across NE — which companies pay providers there.
